As Chief Science Officer, Terry Blaschke advises us on scientific research operations. His vast involvement in clinical trials, with the FDA and with the pharmaceutical industry, has led to his interest in improving medication adherence and the efficiency of drug development using modeling and simulation.
Terry has over 180 original publications and 65 reviews and chapters and is Professor of Medicine and of Molecular Pharmacology (Emeritus) at Stanford University, Adjunct Professor in the Department of Bioengineering and Therapeutic Sciences at UCSF and Adjunct Professor of Medicine at Indiana University. From 2012 through 2015 he was a Senior Program Officer/Senior Advisor at the Bill and Melinda Gates Foundation.
Dr. Blaschke received his MD from Columbia University and his residency training at UCLA. Following fellowship training in Clinical Pharmacology at UCSF he joined the Stanford faculty in 1974. He is past president of the American Society for Clinical Pharmacology and Therapeutics, recipient of the Oscar B. Hunter award from ASCPT and the 2014 Award in Excellence in Clinical Pharmacology from the PhRMA Foundation. He was a member of the AIDS Clinical Trials Group at its inception, and served as chair of the Pharmacology Committee and on the Executive Committee. His research has focused on HIV infection, emphasizing the modeling of exposure-response relationships and adherence, especially in resource-limited settings.